GenomIntelligence™
Keeps the child's whole raw genome in under one percent of the space, and gives every bit of it back. A genome read once can answer every later question.

An end-to-end autism solution built on multi-omics and organoids.
We see the world differently. The world sees us differently.
We sense the world differently. The world feels differently about us.
We yearn to know how to connect.
Love carries us. Empathy makes us keep going. But science will free us.
One day, we want to be seen, found and named — as unknown stars in the galaxy have been.
What we do
Our approach
Five omics layers — WGS, transcriptome, epigenome, biomarkers, microbiome
GenomIntelligence and the SJ Bio foundation model, on a biomedical knowledge graph
Patient-derived organoids — the step where most approaches stop short
Our products — Digital Avatar, Screening tools and PGxomics™
Open architecture — open models and open datasets
Product / Services
01 Diagnosis — cheap, then meaningful
Keeps the child's whole raw genome in under one percent of the space, and gives every bit of it back. A genome read once can answer every later question.
A model built on a biomedical knowledge graph that analyses and screens across the child's biology, and is corrected when a laboratory result disagrees.
02 Treatment — chosen by mechanism, or designed
Tests a medicine in the child's own organoids before the child takes it — matched to the mechanism, dosed for this child, checked for toxicity first.
One child, one design — for the child no existing medicine fits, made in the laboratory that grew the child's organoids.
Blog
27 Sep 2026
That is the definition of a platform. It means the second patient shouldn't cost what the first one did.
Read the post27 Sep 2026
Leroy Hood proposed P4 Medicine — Predictive, Preventive, Personalized, Participatory — more than a decade ago. A fifth P, Precision, has since been added, because the molecular resolution it demands is now routinely achievable.
Read the post27 Sep 2026
have no approved treatment at all.
Read the postContact us